Kyowa Kirin Co., Ltd.

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Kyowa Kirin Co., Ltd. is a clinical trial sponsor. It has 15 active clinical trials with 1,463 planned participants, across 15 therapeutic areas. Since 2021 it has completed 86 trials and stopped 14 early.

Trial track record · since 2021

15Active trials1,463 planned participants
86Completed25 with results posted
14Stopped early14% of finished trials

Pipeline · 15 active trials

StageTrialStatus

On the market

3 approved drug applications with a product on the market.

Questions about Kyowa Kirin Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Kyowa Kirin Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.